Acetylsalicylic acid as an adjuvant therapy for schizophrenia

BACKGROUND: Findings from both epidemiological and basic research point to the possibility that NSAIDS impede the deterioration in schizophrenia. METHODS: To study the efficacy of acetylsalicylic acid we will perform a randomized placebo controlled double-blind add-on trial of 80 inpatients and outp...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Laan, Wijnand, Selten, Jean-Paul, Kahn, René S, Huisman, Anne-Margriet, Heijnen, Cobi J, Grobbee, Diederick E, Burger, Huibert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2006
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1626076/
https://ncbi.nlm.nih.gov/pubmed/17059588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-7-31
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak